有效的中和抗体诱导由人类帕尔沃病毒B19表皮呈现蛋白质纳米粒子
Sakika Kimura1, Hidehiko Suzuki2,3, Yu Hatakeyama1
1Department of Biochemistry and Molecular Biology, Faculty of Agriculture and Life Science, Hirosaki University, Hirosaki, Japan.
Microbiology and immunology
|November 15, 2024
概括
开发一种针对人类帕维病毒B19 (B19V) 的新型纳米粒子疫苗显得有前途. 工程B19V纳米粒子有效地引起强烈的抗体反应和中和活性,表明作为B19V感染的疫苗候选人的潜力.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 人类帕沃病毒B19 (B19V) 是一个重要的病原体,在孕妇中引起胎儿水.
- 目前针对B19V的有效疫苗策略仍未得到充分发展.
研究的目的:
- 为增强免疫性而设计B19V蛋白纳米颗粒.
- 评估这些纳米粒子作为潜在的疫苗候选物的有效性.
主要方法:
- B19V VP1 N端受体结合域 (VP1u 5-80) 与自组装蛋白质纳米颗粒的融合.
- 使用凝过和电子显微镜对纳米粒子组件的表征.
- 对纳米粒子与B19V细胞结合的评估 (UT7/Epo-S1).
- 用纳米颗粒对小鼠进行免疫接种,并评估抗体的产生和中和活性.
主要成果:
- 成功设计了球形B19V抗原融合纳米粒子.
- 纳米颗粒证明有效地与易受性宿主细胞结合.
- 用纳米颗粒免疫在小鼠中诱导了强大的B19V特异性IgG抗体的产生.
- 通过纳米粒子免疫生成的抗体显示出增强的B19V感染中和活性.
结论:
- 纳米颗粒的形成显著提高了B19V VP1u 5-80的免疫性.
- 工程B19V纳米颗粒代表了诱导B19V免疫力的有希望的疫苗候选人.
- 这种方法提供了一种潜在的策略来打击与B19V相关的健康问题,包括胎儿水.
更多相关视频
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
3.6K
相关概念视频
01:40Cell-mediated Immune Responses
Overview
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...